File:R and D management group, May 1982 Wellcome L0075253.jpg
Original file (5,557 × 5,126 pixels, file size: 9.65 MB, MIME type: image/jpeg)
Captions
Summary
editR and D management group, May 1982 | |||
---|---|---|---|
Title |
R and D management group, May 1982 |
||
Description |
Group portrait of R and D Management Group in Foundation News, house journal of The Wellcome Foundation Ltd. Accompanying photography for article "Zovirax given go ahead on two new fronts". Zovirax was Wellcome's breakthrough drug for the treatment of herpes virus infections and was approved in two new formulations. Caption : Transatlantic collaboration programmes for the groups two major research sites at Beckenham and Research Triangle Park were among the main topics of discussion at the ninth group R and D management meeting. Also under review at the recent meeting were further developments in the Zovirax range and other potential products nearing the market. Chairman, Mr. A. J. Sheppard, joined the group for the final sessions to hear a summary of the discussions. Attending the meeting, which was held at Gravetye Manor, East Grinstead, UK, were group R and D director, Dr John Vane (seated, second right), and group technical director, Dr Ronnie Cresswell (seated, right). The other senior staff from both sides of the Atlantic were (seated from left), Dr James Black and Dr Pedro Cuatrecasas. Standing from left: Drs Howard Schaeffer, Win Singleton, George Lyon, John Beale, Douglas Munro-Faure and Mr Warwick Dench. Archives & Manuscripts |
||
Credit line |
|
||
References |
|
||
Source/Photographer |
https://wellcomeimages.org/indexplus/obf_images/fe/e9/a941d7f3de5950744971c8ddb8bd.jpg |
Licensing
edit- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 03:33, 22 October 2014 | 5,557 × 5,126 (9.65 MB) | Fæ (talk | contribs) | =={{int:filedesc}}== {{Artwork |artist = |author = |title = R and D management group, May 1982 |description = Group portrait of R and D Management Group in Foundation News, house journal of The Wellcome Found... |
You cannot overwrite this file.
File usage on Commons
The following page uses this file:
File usage on other wikis
The following other wikis use this file:
- Usage on cs.wikipedia.org
Metadata
This file contains additional information such as Exif metadata which may have been added by the digital camera, scanner, or software program used to create or digitize it. If the file has been modified from its original state, some details such as the timestamp may not fully reflect those of the original file. The timestamp is only as accurate as the clock in the camera, and it may be completely wrong.
Short title | L0075253 R and D management group, May 1982 |
---|---|
Author | Wellcome Library, London |
Headline | L0075253 R and D management group, May 1982 |
Copyright holder | Copyrighted work available under Creative Commons Attribution only licence CC BY 4.0 http://creativecommons.org/licenses/by/4.0/ |
Image title | L0075253 R and D management group, May 1982
Credit: Wellcome Library, London. Wellcome Images images@wellcome.ac.uk http://wellcomeimages.org Group portrait of R and D Management Group in Foundation News, house journal of The Wellcome Foundation Ltd. Accompanying photography for article "Zovirax given go ahead on two new fronts". Zovirax was Wellcome's breakthrough drug for the treatment of herpes virus infections and was approved in two new formulations. Caption : Transatlantic collaboration programmes for the groups two major research sites at Beckenham and Research Triangle Park were among the main topics of discussion at the ninth group R and D management meeting. Also under review at the recent meeting were further developments in the Zovirax range and other potential products nearing the market. Chairman, Mr. A. J. Sheppard, joined the group for the final sessions to hear a summary of the discussions. Attending the meeting, which was held at Gravetye Manor, East Grinstead, UK, were group R and D director, Dr John Vane (seated, second right), and group technical director, Dr Ronnie Cresswell (seated, right). The other senior staff from both sides of the Atlantic were (seated from left), Dr James Black and Dr Pedro Cuatrecasas. Standing from left: Drs Howard Schaeffer, Win Singleton, George Lyon, John Beale, Douglas Munro-Faure and Mr Warwick Dench. May 1982 Wellcome Foundation Archive Foundation News Foundation News Published: May 1982 Copyrighted work available under Creative Commons Attribution only licence CC BY 4.0 http://creativecommons.org/licenses/by/4.0/ |
IIM version | 2 |